ASIA VITAL COMPONENTS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 642 TWD | +3.55% |
|
+1.90% | +90.79% |
| Mar. 18 | Asia Vital Components Co., Ltd.(TWSE:3017) added to FTSE All-World Index | CI |
| Mar. 13 | Asia Vital Components Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 14,715 | 23,354 | 31,162 | 39,571 | 128,984 | 246,085 | - | - |
| Enterprise Value (EV) 1 | 14,715 | 18,995 | 26,976 | 30,814 | 114,987 | 227,136 | 220,380 | 213,172 |
| P/E ratio | - | - | - | - | 23.8 x | 34.3 x | 23.7 x | 17.9 x |
| Yield | - | 4.24% | 3.74% | 4.04% | 2.08% | 1.28% | 1.79% | 2.79% |
| Capitalization / Revenue | 0.4 x | 0.59 x | 0.66 x | 0.71 x | 2.18 x | 3.51 x | 2.81 x | 2.61 x |
| EV / Revenue | 0.4 x | 0.48 x | 0.57 x | 0.55 x | 1.94 x | 3.24 x | 2.51 x | 2.26 x |
| EV / EBITDA | - | 4.22 x | 4.21 x | 3.84 x | 12.3 x | 18.3 x | 12.7 x | 10.2 x |
| EV / FCF | - | 7.72 x | 20.7 x | 5.92 x | 17.2 x | 34.9 x | 20.9 x | 17.7 x |
| FCF Yield | - | 13% | 4.82% | 16.9% | 5.8% | 2.87% | 4.79% | 5.66% |
| Price to Book | - | 2.21 x | 2.51 x | 2.55 x | 5.86 x | 8.83 x | 7.26 x | 5.47 x |
| Nbr of stocks (in thousands) | 353,310 | 353,310 | 353,310 | 353,310 | 383,310 | 383,310 | - | - |
| Reference price 2 | 41.65 | 66.10 | 88.20 | 112.0 | 336.5 | 642.0 | 642.0 | 642.0 |
| Announcement Date | 3/12/20 | 3/22/21 | 3/18/22 | 3/13/23 | 3/13/24 | - | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 36,534 | 39,666 | 47,333 | 56,017 | 59,194 | 70,107 | 87,636 | 94,353 |
| EBITDA 1 | - | 4,496 | 6,404 | 8,021 | 9,375 | 12,395 | 17,303 | 20,882 |
| EBIT 1 | 1,259 | 3,260 | 4,827 | 6,306 | 7,421 | 10,409 | 14,919 | 18,588 |
| Operating Margin | 3.45% | 8.22% | 10.2% | 11.26% | 12.54% | 14.85% | 17.02% | 19.7% |
| Earnings before Tax (EBT) 1 | - | - | - | - | 8,025 | 10,824 | 15,817 | 19,642 |
| Net income 1 | - | - | - | - | 5,305 | 7,147 | 10,344 | 13,722 |
| Net margin | - | - | - | - | 8.96% | 10.2% | 11.8% | 14.54% |
| EPS 2 | - | - | - | - | 14.11 | 18.70 | 27.11 | 35.80 |
| Free Cash Flow 1 | - | 2,462 | 1,301 | 5,204 | 6,667 | 6,512 | 10,554 | 12,066 |
| FCF margin | - | 6.21% | 2.75% | 9.29% | 11.26% | 9.29% | 12.04% | 12.79% |
| FCF Conversion (EBITDA) | - | 54.76% | 20.32% | 64.88% | 71.11% | 52.54% | 60.99% | 57.78% |
| FCF Conversion (Net income) | - | - | - | - | 125.68% | 91.11% | 102.03% | 87.93% |
| Dividend per Share 2 | - | 2.800 | 3.300 | 4.520 | 7.000 | 8.214 | 11.49 | 17.90 |
| Announcement Date | 3/12/20 | 3/22/21 | 3/18/22 | 3/13/23 | 3/13/24 | - | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 12,593 | 13,764 | 14,883 | 14,777 | 11,835 | 14,871 | 15,769 | 16,720 | 15,384 | 15,998 | 18,448 | 20,169 | 19,040 |
| EBITDA 1 | - | - | - | - | - | - | - | 2,949 | 2,991 | 3,104 | 3,755 | 4,348 | - |
| EBIT 1 | 1,336 | 1,528 | 1,756 | 1,686 | 1,352 | 1,547 | 2,105 | 2,416 | 2,181 | 2,227 | 2,800 | 3,250 | 3,097 |
| Operating Margin | 10.61% | 11.1% | 11.8% | 11.41% | 11.43% | 10.41% | 13.35% | 14.45% | 14.18% | 13.92% | 15.18% | 16.11% | 16.27% |
| Earnings before Tax (EBT) 1 | - | - | - | - | - | - | 2,220 | 2,491 | 2,316 | 2,342 | 2,892 | 3,275 | 3,487 |
| Net income 1 | - | - | - | - | - | - | 1,426 | 1,671 | 1,547 | 1,531 | 1,902 | 2,167 | 2,341 |
| Net margin | - | - | - | - | - | - | 9.04% | 9.99% | 10.06% | 9.57% | 10.31% | 10.74% | 12.3% |
| EPS 2 | - | - | - | - | - | - | 3.720 | 4.360 | 4.063 | 4.021 | 4.994 | 5.688 | 5.792 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 5/11/22 | 8/9/22 | 11/11/22 | 3/13/23 | 5/10/23 | 8/9/23 | 11/10/23 | 3/13/24 | - | - | - | - | - |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 4,358 | 4,185 | 8,757 | 13,997 | 18,949 | 25,705 | 32,913 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | 2,462 | 1,301 | 5,204 | 6,667 | 6,512 | 10,554 | 12,066 |
| ROE (net income / shareholders' equity) | - | 19.6% | 25.2% | 29.8% | 28.3% | 28.3% | 32.9% | 33.7% |
| ROA (Net income/ Total Assets) | - | 5.03% | - | - | 8.03% | 9.88% | 13% | 14.4% |
| Assets 1 | - | - | - | - | 66,070 | 72,351 | 79,608 | 95,292 |
| Book Value Per Share 2 | - | 29.90 | 35.10 | 43.90 | 57.50 | 72.70 | 88.40 | 117.0 |
| Cash Flow per Share 2 | - | - | - | - | 26.70 | 16.10 | 21.40 | - |
| Capex 1 | - | 2,407 | 1,540 | 3,636 | 3,657 | 3,482 | 3,268 | 2,500 |
| Capex / Sales | - | 6.07% | 3.25% | 6.49% | 6.18% | 4.97% | 3.73% | 2.65% |
| Announcement Date | 3/12/20 | 3/22/21 | 3/18/22 | 3/13/23 | 3/13/24 | - | - | - |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
642
TWD
Average target price
735
TWD
Spread / Average Target
+14.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +90.79% | 7.54B | |
| +63.48% | 89.27B | |
| -6.95% | 27.4B | |
| +1.12% | 22.32B | |
| +0.78% | 18.07B | |
| -8.90% | 12.3B | |
| +9.13% | 10.03B | |
| +14.60% | 9.94B | |
| -14.40% | 9.54B | |
| +17.98% | 9.41B |
- Stock Market
- Equities
- 3017 Stock
- Financials Asia Vital Components Co., Ltd.
